<?xml version="1.0" encoding="UTF-8"?>
<ref id="bjh15459-bib-0014">
 <mixed-citation publication-type="journal" id="bjh15459-cit-0014">
  <string-name>
   <surname>Morgan</surname>, 
   <given-names>G.J.</given-names>
  </string-name>, 
  <string-name>
   <surname>Davies</surname>, 
   <given-names>F.E.</given-names>
  </string-name>, 
  <string-name>
   <surname>Gregory</surname>, 
   <given-names>W.M.</given-names>
  </string-name>, 
  <string-name>
   <surname>Bell</surname>, 
   <given-names>S.E.</given-names>
  </string-name>, 
  <string-name>
   <surname>Szubert</surname>, 
   <given-names>A.J.</given-names>
  </string-name>, 
  <string-name>
   <surname>Navarro Coy</surname>, 
   <given-names>N.</given-names>
  </string-name>, 
  <string-name>
   <surname>Cook</surname>, 
   <given-names>G.</given-names>
  </string-name>, 
  <string-name>
   <surname>Feyler</surname>, 
   <given-names>S.</given-names>
  </string-name>, 
  <string-name>
   <surname>Johnson</surname>, 
   <given-names>P.R.</given-names>
  </string-name>, 
  <string-name>
   <surname>Rudin</surname>, 
   <given-names>C.</given-names>
  </string-name>, 
  <string-name>
   <surname>Drayson</surname>, 
   <given-names>M.T.</given-names>
  </string-name>, 
  <string-name>
   <surname>Owen</surname>, 
   <given-names>R.G.</given-names>
  </string-name>, 
  <string-name>
   <surname>Ross</surname>, 
   <given-names>F.M.</given-names>
  </string-name>, 
  <string-name>
   <surname>Russell</surname>, 
   <given-names>N.H.</given-names>
  </string-name>, 
  <string-name>
   <surname>Jackson</surname>, 
   <given-names>G.H.</given-names>
  </string-name> &amp; 
  <string-name>
   <surname>Child</surname>, 
   <given-names>J.A.</given-names>
  </string-name>; 
  <collab collab-type="authors">National Cancer Research Institute Haematological Oncology Clinical Studies Group</collab> . (
  <year>2012a</year>) 
  <article-title>Cyclophosphamide, thalidomide, and dexamethasone as induction therapy for newly diagnosed multiple myeloma patients destined for autologous stem‐cell transplantation: MRC Myeloma IX randomized trial results</article-title>. 
  <source xml:lang="en">Haematologica</source>, 
  <volume>97</volume>, 
  <fpage>442</fpage>–
  <lpage>450</lpage>.
  <pub-id pub-id-type="pmid">22058209</pub-id>
 </mixed-citation>
</ref>
